BCMA Targeted Therapies
Evvnt Promotion / evvnt
12.07.2022 - 14.07.2022 The Bostonian, 26 North Street, 02109 Boston, Massachusetts, USA
Time: 9:00 AM - 4:30 PM
Kongressthemen
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anfragen und Anmeldung:
https://go.evvnt.com/1093163-2?pid=4832
Herr Hanson Wade
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
